Business Wire1h
Devonian Announces the Filing of a New Provisional Patent Application Relating to the Use of Thykamine™ for Treating Metabolic Dysfunction-Associated Steatohepati…
Devonian Health Group Inc. (“Devonian” or the “Company”) (TSXV: GSD; OTCQB: DVHGF), a clinical stage corporation focused on ...
Healio10h
Stelara, Entyvio have ‘comparable’ cardiovascular safety profiles in older adults with IBD
Although Stelara and Entyvio demonstrated similar cardiovascular safety profiles among older patients with inflammatory bowel ...
Business Wire2h
Devonian Reports Positive Results in MASH Liver Study
Devonian Health Group Inc. (“Devonian” or the “Company”) (TSXV: GSD; OTCQB: DVHGF), a clinical stage corporation focused on developing unique solution ...
pharmaphorum23h
BMS eyes May FDA verdict for MS drug Zeposia in ulcerative colitis
Orally-active S1P agonist Zeposia (ozanimod) has been submitted to the FDA as a treatment for adults with moderately to severely active ulcerative colitis (UC), with a decision from the US ...
Nature23h
The researchers on a quest to protect the gut from antibiotics
The crucial drugs can have unintended consequences. Innovative therapies could shield the microbiome from their effects.